Perkins Adelene Q 4
4 · INFINITY PHARMACEUTICALS, INC. · Filed Mar 7, 2018
Insider Transaction Report
Form 4
Perkins Adelene Q
Pres & Chief Business Officer
Transactions
- Sale
Common Stock
2018-03-05$2.78/sh−5,000$13,890→ 607,252 total
Holdings
- 12,391.26(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]The disposition reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2017.